Peptide therapy claims on TikTok: separating signal from noise

What's this video probably claiming?

Given the @confyhair creator context and the peptide category tag, this video likely touches on one or more popular research peptides, possibly BPC-157, TB-500, or the GH secretagogue stack of CJC-1295 with ipamorelin. Creators in this space typically frame these compounds as accessible, low-risk alternatives to prescription therapeutics, often with personal anecdote as the primary evidence. The messaging usually centers on accelerated recovery, body composition changes, or vague "optimization" language. Hair-focused creators sometimes pivot to GHK-Cu, a copper peptide with genuine topical research but a much murkier story for injectable or systemic forms. Expect claims about healing, growth hormone pulses, or anti-inflammatory effects presented with a confidence that the underlying evidence does not fully support. The lack of a hashtag trail here actually makes the content harder to predict, which is itself a yellow flag for regulatory compliance.

What does the science actually show?

The honest answer is: it depends enormously on which peptide and which outcome. BPC-157 has legitimate rodent data. Sikiric et al. (2018, Current Pharmaceutical Design) documented accelerated tendon and gut healing in rat models at doses around 10 mcg/kg, but zero completed randomized controlled trials exist in humans as of 2024. TB-500 (thymosin beta-4) has one published Phase II trial in cardiac patients (Sopko et al., 2020, Frontiers in Pharmacology) showing modest angiogenesis signals, not the broad tissue repair TikTok promises. CJC-1295 with ipamorelin raises IGF-1 measurably. Alba et al. (2005, Journal of Clinical Endocrinology and Metabolism) showed CJC-1295 alone increased mean IGF-1 by 28-39% over 28 days at 30-60 mcg/kg doses. Whether that translates to meaningful body composition change in healthy adults is a separate, largely unanswered question. GHK-Cu has solid topical wound-healing data (Pickart and Margolina, 2018, Biomolecules) but injectable systemic use in humans remains essentially unstudied.

Where does the social media noise diverge from clinical reality?

The gap is wide and it runs in a predictable direction. Social media compresses "animal data exists" into "this works," skips dose-response uncertainty entirely, and rarely mentions that most of these peptides are sold as research chemicals with no manufacturing quality controls binding the seller. Purity testing by independent labs like Janoshik has repeatedly found peptide products with significant concentration variance, sometimes 20-40% off label claims. Creators also routinely conflate subcutaneous injection protocols with the conditions used in published studies, which often use intraperitoneal injection in rodents, a completely different pharmacokinetic profile. The growth hormone secretagogue content almost never mentions that MK-677, frequently bundled into these conversations, is an orally active ghrelin mimetic, not a true peptide, with its own incomplete safety record. Sigalos and Pastuszak (2018, Sexual Medicine Reviews) noted appetite increase and fluid retention as consistent adverse effects even at "research doses."

What should you actually know?

None of these compounds are FDA-approved for the indications being discussed on TikTok. The FDA issued a guidance in 2023 placing BPC-157 and several related peptides on a list of substances that cannot be compounded under 503A or 503B, citing insufficient evidence of safety and effectiveness. That matters because it affects whether a licensed telehealth platform can legally offer them. If you're considering peptide therapy, the questions worth asking are: what is the specific human evidence for my specific goal, what is the compounding pharmacy's third-party testing protocol, and what monitoring does the prescribing provider plan to do. Growth hormone secretagogues in particular warrant IGF-1 monitoring given the theoretical concern about promoting cell proliferation in undiagnosed malignancies. That concern is theoretical, not proven, but it is not nothing. Any provider who dismisses it without discussion is not giving you complete information.